Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions

被引:85
作者
Getahun, Haileyesus [1 ]
Granich, Reuben [2 ]
Sculier, Delphine [1 ]
Gunneberg, Christian [1 ]
Blanc, Leopold [1 ]
Nunn, Paul [1 ]
Raviglione, Mario [1 ]
机构
[1] WHO, Stop TB Dept, CH-1211 Geneva 27, Switzerland
[2] WHO, HIV AIDS Dept, CH-1211 Geneva 27, Switzerland
关键词
barrier; HIV; INH; isoniazid preventive therapy; prevention; solution; Tuberculosis; LATENT TUBERCULOSIS INFECTION; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; MORTALITY; ADULTS; PROPHYLAXIS; PREVALENCE; TRIAL; RISK;
D O I
10.1097/01.aids.0000391023.03037.1f
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:S57 / S65
页数:9
相关论文
共 62 条
[1]   Treatment of latent tuberculosis infection in HIV infected persons [J].
Akolo, Christopher ;
Adetifa, Ifedayo ;
Shepperd, Sasha ;
Volmink, Jimmy .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01)
[2]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[3]  
[Anonymous], 2009, Progress Report'
[4]  
[Anonymous], 1993, WKLY EPIDEMIOL REC, V68, P361
[5]  
[Anonymous], 2008, WHO 3 IS M
[6]  
[Anonymous], 2009, GLOB TUB CONTR SHORT
[7]  
[Anonymous], 3 INT PAT MON SYST H
[8]  
[Anonymous], 2004, Interim policy on collaborative TB/HIV activities
[9]  
[Anonymous], 2009, GUID SURV DRUG RES T, V4
[10]  
[Anonymous], 2010, GUID INT TUB CAS FIN